ArticleOncotarget2015

Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents.

Vit Sestak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.